1
|
Agilli M, Aydin FN, Cayci T and Kurt YG:
Assessment of active mucosal inflammation in IBD patients in
clinical remission. J Gastrointestin Liver Dis. 23:462–463.
2014.PubMed/NCBI
|
2
|
Dunkin D, Mehandru S and Colombel JF:
Immune cell therapy in IBD. Dig Dis. 32:(Suppl 1). S61–S66. 2014.
View Article : Google Scholar
|
3
|
Hildner K, Punkenburg E, Abendroth B and
Neurath MF: Immunopathogenesis of IBD: Batf as a Key Driver of
Disease Activity. Dig Dis 34 (Suppl 1). 40–47. 2016.
|
4
|
De Salvo C, Ray S and Pizarro TT:
Mechanisms and models for intestinal fibrosis in IBD. Dig Dis.
32:(Suppl 1). S26–S34. 2014. View Article : Google Scholar
|
5
|
Latella G, Di Gregorio J, Flati V, Rieder
F and Lawrance IC: Mechanisms of initiation and progression of
intestinal fibrosis in IBD. Scand J Gastroenterol. 50:53–65. 2015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Bryant RV, Brain O and Travis SP:
Conventional drug therapy for inflammatory bowel disease. Scand J
Gastroenterol. 50:90–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chen M, Yi F, Zhou F, Huang M, Li J, Yan
W, Li L and Xia B: Risk factors for initial surgery in patients
with Crohn's disease in Central China. Surg Today. 45:1002–1008.
2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Connelly TM, Koltun WA, Sangster W, Berg
AS, Hegarty JP, Harris L III, Deiling S and Stewart DB: An
interleukin-4 polymorphism is associated with susceptibility to
Clostridium difficile infection in patients with inflammatory bowel
disease: Results of a retrospective cohort study. Surgery.
156:769–774. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Katz LH, Kopylov U, Fudim E, Yavzori M,
Picard O, Ungar B, Eliakim R, Ben-Horin S and Chowers Y: Expression
of IL-2, IL-17 and TNF-alpha in patients with Crohn's disease
treated with anti-TNF antibodies. Clin Res Hepatol Gastroenterol.
38:491–498. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zatorski H, Marynowski M and Fichna J: Is
insulin-like growth factor 1 (IGF-1) system an attractive target
inflammatory bowel diseases? Benefits and limitation of potential
therapy. Pharmacol Rep. 68:809–815. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nata T, Fujiya M, Ueno N, Moriichi K,
Konishi H, Tanabe H, Ohtake T, Ikuta K and Kohgo Y: MicroRNA-146b
improves intestinal injury in mouse colitis by activating nuclear
factor-kB and improving epithelial barrier function. J Gene Med.
15:249–260. 2013. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Chen JY, Hour TC, Yang SF, Chien CY, Chen
HR, Tsai KL, Ko JY and Wang LF: Autophagy is deficient in nasal
polyps: Implications for the pathogenesis of the disease. Int Forum
Allergy Rhinol. 5:119–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu H, He Z and Simon HU: Protective role
of autophagy and autophagy-related protein 5 in early
tumorigenesis. J Mol Med (Berl). 93:159–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Annese V, Duricova D, Gower-Rousseau C,
Jess T and Langholz E: Impact of New Treatments on Hospitalisation,
Surgery, Infection, and Mortality in IBD: A Focus Paper by the
Epidemiology Committee of ECCO. J Crohns Colitis. 10:216–225. 2016.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Murthi P, van Zanten DE, Eijsink JJ, Borg
AJ, Stevenson JL, Kalionis B, Chui AK, Said JM, Brennecke SP and
Erwich JJ: Decorin expression is decreased in first trimester
placental tissue from pregnancies with small for gestation age
infants at birth. Placenta. 45:58–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Nemani N, Santo L, Eda H, Cirstea D,
Mishima Y, Patel C, O'Donnell E, Yee A and Raje N: Role of decorin
in multiple myeloma (MM) bone marrow microenvironment. J Bone Miner
Res. 30:465–470. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Esmaeili M, Berry M, Logan A and Ahmed Z:
Decorin treatment of spinal cord injury. Neural Regen Res.
9:1653–1656. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kasamatsu A, Uzawa K, Minakawa Y, Ishige
S, Kasama H, Endo-Sakamoto Y, Ogawara K, Shiiba M, Takiguchi Y and
Tanzawa H: Decorin in human oral cancer: A promising predictive
biomarker of S-1 neoadjuvant chemosensitivity. Biochem Biophys Res
Commun. 457:71–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Araki K, Wakabayashi H, Shintani K,
Morikawa J, Matsumine A, Kusuzaki K, Sudo A and Uchida A: Decorin
suppresses bone metastasis in a breast cancer cell line. Oncology.
77:92–99. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Reed CC, Waterhouse A, Kirby S, Kay P,
Owens RT, McQuillan DJ and Iozzo RV: Decorin prevents metastatic
spreading of breast cancer. Oncogene. 24:1104–1110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Obba S, Hizir Z, Boyer L, Selimoglu-Buet
D, Pfeifer A, Michel G, Hamouda MA, Gonçalvès D, Cerezo M,
Marchetti S, et al: The PRKAA1/AMPKα1 pathway triggers autophagy
during CSF1-induced human monocyte differentiation and is a
potential target in CMML. Autophagy. 11:1114–1129. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Cheng X, Zhang X, Su J, Zhang Y, Zhou W,
Zhou J, Wang C, Liang H, Chen X, Shi R, et al: miR-19b
downregulates intestinal SOCS3 to reduce intestinal inflammation in
Crohn's disease. Sci Rep. 5:103972015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zeng TS, Liu FM, Zhou J, Pan SX, Xia WF
and Chen LL: Depletion of Kupffer cells attenuates systemic insulin
resistance, inflammation and improves liver autophagy in high-fat
diet fed mice. Endocr J. 62:615–626. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Mauviel A, Santra M, Chen YQ, Uitto J and
Iozzo RV: Transcriptional regulation of decorin gene expression.
Induction by quiescence and repression by tumor necrosis
factor-alpha. J Biol Chem. 270:11692–11700. 1995. View Article : Google Scholar : PubMed/NCBI
|
25
|
Schaefer L, Macakova K, Raslik I, Micegova
M, Gröne HJ, Schönherr E, Robenek H, Echtermeyer FG, Grässel S,
Bruckner P, et al: Absence of decorin adversely influences
tubulointerstitial fibrosis of the obstructed kidney by enhanced
apoptosis and increased inflammatory reaction. Am J Pathol.
160:1181–1191. 2002. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tomasello G, Sinagra E, Raimondo D,
Palumbo VD, Puleio R, Cottone M, Damiani P, Traina G, Abruzzo A,
Damiani F, et al: Validation of a modified model of TNBS-induced
colitis in rats. How to induce a chemical colitis in rats. Acta
Biomed. 86:92–96. 2015.PubMed/NCBI
|